Webinars

Triage of HPV-positive patients with p16/Ki67 dual staining biomarkers in the USA and China

Triage of HPV-positive patients with p16/Ki67 dual staining biomarkers in the USA and China

In this webinar on using p16/Ki67 dual staining biomarkers in the triage of HPV-positive patients, experts from the United States and China share their experiences with these biomarkers in their routine clinical practices. As a gynaecological oncologist at UVA Health, Professor Leigh Cantrell emphasises that explaining the science behind HPV and its role in cervical […]

Triage of HPV-positive patients with p16/Ki67 dual staining biomarkers in the USA and China Read More »

Optimising triage of HPV-positive patients with p16/Ki67 dual staining biomarkers

Advancing women’s health: key takeaways from AOGIN 2022

In this webinar on optimising triage of HPV-positive patients with the use of  p16/Ki67 dual staining biomarkers, two experts from Singapore General Hospital share their experiences with the use of this triage method. Prof Tay Sun Kuie, Clinical Professor and Senior Consultant OB/GYN and Dr Sangeeta Mantoo, Senior Consultant at the Department of Anatomical Pathology,

Optimising triage of HPV-positive patients with p16/Ki67 dual staining biomarkers Read More »

Early stage lung cancer: Asia’s evolving testing and treatment landscape

Early stage lung cancer Asia’s evolving testing and treatment landscape_thumb

Lung cancer has seen tremendous advances over the past decade with the emergence of targeted therapies directed against mutant onco-proteins and immune checkpoint inhibitors, including several that are being applied outside of the advanced metastatic setting. In a recent webinar hosted by Dr Jennifer Thompson, Oncology Medical & Scientific Affairs Manager at Roche Diagnostics Asia

Early stage lung cancer: Asia’s evolving testing and treatment landscape Read More »

Coagulation during COVID-19 and beyond: diagnostic challenges and opportunities

Addressing diagnostic challenges in coagulation during COVID-19 and beyond

The ongoing COVID-19 pandemic has had a profound worldwide impact on the Thrombosis and Hemostasis community. Nevertheless, the pace of COVID-19 coagulation-related research has continued to accelerate and has established the role of laboratory coagulation data for many purposes, including disease prognosis and outcome. Although the pathogenesis of the COVID-19-induced coagulopathy has not yet been

Coagulation during COVID-19 and beyond: diagnostic challenges and opportunities Read More »

Challenges in immunohistochemistry assays explained

Screenshot of challenges in immunohistochemistry assays explained talk

Learn from Dr Lupe Manriquez, principal pathologist at Roche Tissue Diagnostics USA, as she talks about the best practices for immunohistochemistry staining in the preanalytical phase. Dr Manriquez highlights the common issues raised in preparation and staining by showing real case examples for each topic. Fixation and Slide Type [02:34] Background Staining [11:24] Specific vs.

Challenges in immunohistochemistry assays explained Read More »

The value of external quality assessment for histopathology laboratories

16 dec td webinar thumbnail 2

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Dr Anne Waydelich, a scientist in the Medical & Scientific Affairs group at Roche Diagnostics EMEA LATAM, shares her experiences with external quality assessment (EQA) programmes. Dr Waydelich notes that quality controls are integral in validating results, but a meta analysis has shown that 70%

The value of external quality assessment for histopathology laboratories Read More »

Verification and validation: an overview for IHC assays

16 dec td webinar thumbnail 2

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Dr Bharathi Vennapusa, a pathologist working with the Medical & Scientific Affairs field team at Roche Diagnostics USA, discusses the overarching points to consider when it comes to commercially available IHC tests. She emphasises the importance of lab quality management systems and how FDA approvals

Verification and validation: an overview for IHC assays Read More »

Digital pathology and MDTs in ophthalmology: a case study from Australia

Onco Diagnostics Webinar Series_thumbnail

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Assoc. Professor Svetlana Cherepanoff, a staff specialist anatomical pathologist at St Vincent’s Hospital in Australia with research interests in ocular pathology, shares her experience using digital pathology, NGS and digital collaboration tools for better and more accurate diagnosis. Cherepanoff gives examples of how these technologies

Digital pathology and MDTs in ophthalmology: a case study from Australia Read More »

COVID-19 testing: Prof Aw Tar Choon on PCR, antigen and serology strategies

Aw Tar Choon webinar thumbnail

In a recent webinar hosted by Roche Diagnostics Asia Pacific, Professor Aw Tar Choon, Senior Consultant at the Department of Laboratory Medicine at Singapore’s Changi General Hospital, shares key updates on COVID-19 testing, including the growing array of rapid tests that provide quick return on results. Prof Aw explores the viral kinetics of SARS-CoV-2, which

COVID-19 testing: Prof Aw Tar Choon on PCR, antigen and serology strategies Read More »

Oncologist-pathologist communication underpins successful care teams

Lung cancer diagnostics in oncologist-pathologist care teams

Professor Keith Kerr, Chair of Pulmonary Pathology of the University of Aberdeen, raises the need for a holistic approach when it comes to informing a patient’s journey. In this recent webinar hosted by Roche Diagnostics Asia Pacific, Professor Kerr highlights that communication and mutual understanding within members of a team underpins successful patient management, from

Oncologist-pathologist communication underpins successful care teams Read More »

Scroll to Top